A study examined the survival times of cancer patients treated with ascorbate based on the affected organ. A one-way ANOVA was conducted to determine if survival times differed significantly between stomach, bronchus, colon, ovary and breast cancer patients. The ANOVA indicated that at least two of the survival time means were significantly different. Post-hoc multiple comparisons were needed to identify which specific organ means differed from each other.